FK 506 dose in transplantation: From theory to practice

Transplantation Proceedings

Volumn 33, Issue 4, 2001, Pages 2594-2597

  Faivre, L ^a   Saoudi, S ^a   Astier, A ^b   Hamadas, C ^b   Conort, O ^c   Boivin, H ^c   Sabatier, B ^d   Taburet, A M ^e   Lecointre, K ^e   Bellanger, A ^f   Radideau, E ^f   Thuillier, A ^f  

^a HÔPITAL PAUL BROUSSE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Institut Cochin   (France)

^d HÔPITAL BROUSSAIS   (France)

^e BICÊTRE HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; TACROLIMUS;

ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PARIS; POSTOPERATIVE COMPLICATIONS; TACROLIMUS; TIME FACTORS; TRANSPLANTATION IMMUNOLOGY;

EID: 0034851172     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02107-8     Document Type: Article

References (4)

1. Jusko WJ, Thomson AW, Fung J, et al: Ther Drug Monit 17:606, 1995
2. Wiesner RH: Transplantation 66:493, 1998
3. Jordan ML, Naraghi R, Shapiro R, et al: Transplantation 63:223, 1997
4. Pichlmayr R, Winkler M, Neuhaus P, et al: Transplant Proc 29:2499, 1997